# Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C

> **NCT01402583** · — · COMPLETED · sponsor: **Prof. Facchinetti Fabio** · enrollment: 1000 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** PEG IFN/Ribavirin

## Key facts

- **NCT ID:** NCT01402583
- **Lead sponsor:** Prof. Facchinetti Fabio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2011-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01402583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01402583, "Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01402583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*